Conformational requirements for endocannabinoid interaction with the cannabinoid receptors, the anandamide transporter and fatty acid amidohydrolase (Q34098953)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Conformational requirements for endocannabinoid interaction with the cannabinoid receptors, the anandamide transporter and fatty acid amidohydrolase	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

31 July 2017

1 reference

Europe PubMed Central

Conformational requirements for endocannabinoid interaction with the cannabinoid receptors, the anandamide transporter and fatty acid amidohydrolase (English)

1 reference

Europe PubMed Central

31 July 2017

0 references

endocannabinoids

0 references

0 references

0 references

0 references

cannabinoid receptor

0 references

author name string

P H Reggio

1

1 reference

Europe PubMed Central

31 July 2017

H Traore

2

1 reference

Europe PubMed Central

31 July 2017

publication date

1 November 2000

1 reference

Europe PubMed Central

31 July 2017

Chemistry and Physics of Lipids

1 reference

Europe PubMed Central

31 July 2017

108

1 reference

Europe PubMed Central

31 July 2017

1-2

1 reference

Europe PubMed Central

31 July 2017

15-35

1 reference

Europe PubMed Central

31 July 2017

(R)-methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Pharmacological and behavioral evaluation of alkylated anandamide analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Exploration of biologically relevant conformations of anandamide, 2-arachidonylglycerol, and their analogues using conformational memories

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Functional role of high-affinity anandamide transport, as revealed by selective inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Anandamide transport inhibition by the vanilloid agonist olvanil.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Structural requirements for arachidonylethanolamide interaction with CB1 and CB2 cannabinoid receptors: pharmacology of the carbonyl and ethanolamide groups

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Trifluoromethyl ketone inhibitors of fatty acid amide hydrolase: a probe of structural and conformational features contributing to inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Lipid mimetics: the design and properties of conformationally-restricted arachidonic acid lipidic and peptidic analogues.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Cerebrodiene, arachidonyl-ethanolamide, and hybrid structures: potential for interaction with brain cannabinoid receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Modification of 5-HT2 receptor mediated behaviour in the rat by oleamide and the role of cannabinoid receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Chemical characterization of a family of brain lipids that induce sleep

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Novel Inhibitors of Brain, Neuronal, and Basophilic Anandamide Amidohydrolase

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Anandamide amidohydrolase activity in rat brain microsomes. Identification and partial characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Methyl arachidonyl fluorophosphonate: a potent irreversible inhibitor of anandamide amidase

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Formation and inactivation of endogenous cannabinoid anandamide in central neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Interactions between synthetic vanilloids and the endogenous cannabinoid system

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells: connections with anandamide

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

The binding of novel phenolic derivatives of anandamide to brain cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Human platelets and polymorphonuclear leukocytes synthesize oxygenated derivatives of arachidonylethanolamide (anandamide): their affinities for cannabinoid receptors and pathways of inactivation.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

A new perspective on cannabinoid signalling: complementary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Molecular characterization of human and mouse fatty acid amide hydrolases

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Structure-activity relationships among N-arachidonylethanolamine (Anandamide) head group analogues for the anandamide transporter

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Head group analogs of arachidonylethanolamide, the endogenous cannabinoid ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Reversible hydrolysis and synthesis of anandamide demonstrated by recombinant rat fatty-acid amide hydrolase.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Substrate specificity and stereoselectivity of rat brain microsomal anandamide amidohydrolase.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Novel analogues of arachidonylethanolamide (anandamide): affinities for the CB1 and CB2 cannabinoid receptors and metabolic stability.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Anandamide hydrolysis by human cells in culture and brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Anandamide may mediate sleep induction

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Unique Analogues of Anandamide: Arachidonyl Ethers and Carbamates and Norarachidonyl Carbamates and Ureas

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

An endogenous sleep-inducing compound is a novel competitive inhibitor of fatty acid amide hydrolase

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Structural determinants for recognition and translocation by the anandamide transporter

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

On the conformational, physical properties and functions of polyunsaturated acyl chains

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Conformational analysis of arachidonic and related fatty acids using molecular dynamics simulations

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

The binding of arachidonic acid in the cyclooxygenase active site of mouse prostaglandin endoperoxide synthase-2 (COX-2). A putative L-shaped binding conformation utilizing the top channel region

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Potent Anandamide Analogs: The Effect of Changing the Length and Branching of the End Pentyl Chain

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Synthesis and pharmacological comparison of dimethylheptyl and pentyl analogs of anandamide.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

A second endogenous cannabinoid that modulates long-term potentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Structure-activity analysis of anandamide analogs: relationship to a cannabinoid pharmacophore.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Derivation of a pharmacophore model for anandamide using constrained conformational searching and comparative molecular field analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

The REM sleep-inducing action of a naturally occurring organic bromine compound in the encéphale isolé cat

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Evaluation of cannabimimetic effects of structural analogs of anandamide in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Synthesis and cannabinoid receptor binding activity of conjugated triene anandamide, a novel eicosanoid

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0009-3084(00)00185-7

1 reference

Europe PubMed Central

31 July 2017

1 reference

Europe PubMed Central

31 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34098953&oldid=1539734208"